Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma
Clinical trial NCT04052334 · COMPLETED
Trial details
- NCT number
- NCT04052334
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-27
- Primary completion
- 2023-05-26
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.